A randomized controlled trial has quantified the anti-inflammatory benefits of a specialized tomato-soy juice blend in adults with obesity. Participants who consumed the enhanced formulation daily demonstrated significant reductions across multiple inflammatory biomarkers: TNF-α decreased by 23%, IL-6 by 18%, and CRP by 15%. In stark contrast, the control group receiving standard tomato juice showed only a 3% reduction in these markers. The substantial difference between the intervention and control groups underscores the importance of formulation specificity in nutritional medicine. These measurable improvements in systemic inflammation were achieved within just four weeks, suggesting relatively rapid therapeutic effects. The data highlights how concentrated plant compound synergy can amplify anti-inflammatory benefits beyond conventional approaches, offering clinicians and patients evidence-based nutritional strategies for addressing obesity-related metabolic dysfunction. Read the full article on GMJ Newsroom.
Was this article helpful?
